1 Min Read
Dec 12 (Reuters) - Flexion Therapeutics Inc
* Submits new drug application for Zilretta to treat knee osteoarthritis pain Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.